Clinical Trial Update: Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin [Phase 3]

View source ↗

Summary

TAK-438 (tegoprazan) was evaluated in a long-term extension Phase 3 trial to prevent recurrent gastric or duodenal ulcers in patients on low-dose aspirin. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcers
• Gastric Ulcers

Drugs mentioned

• TAK-438 (vonoprazan)

Snippet

Sponsor: Takeda | Conditions: Gastric Ulcers, Duodenal Ulcers | Phase 3 | Status: COMPLETED